Sarah Ford | September 19, 2013
OCRF Researchers Find Some Immune Cells Aid Cancer Growth
A new OCRF-funded study from researchers at the University of Michigan Comprehensive Cancer Center found that a subset of immune cells, called myeloid derived suppressor cells, do more harm than good by providing a niche where the cancer stem cells survive. The research is published in the journal Immunity.
Cancer stem cells are thought to be resistant to current chemotherapy and radiation treatments, and researchers believe that killing the cancer stem cells is crucial for eliminating cancer.
At the same time that these immune cells help the cancer, they also are suppressing the immune system.
>> Click here to read more.
Source: Ovarian Cancer Research Fund
Get Resources and Insights Straight To Your Inbox
Explore More Articles
How Much Money Does Your Company’s Emergency Assistance Fund Actually Need?
Setting up an Employee Assistance Fund (EAF) is one of the most practical ways to support employees during times of crisis. One of the first…
Before the Storm: A Different Way to Think About Corporate Disaster Giving
Featured on Bright Harbor with insights from our CEO Jim Starr. Ask any corporate giving officer what their disaster response strategy looks like and you’ll…
Emergency Assistance Funds: Corporate Responsibility Begins at Home
The Hard Truth: Employee Financial Stress Directly Impacts the Workplace Approximately 2 in 5 Americans, or 37%, say they could not afford an emergency expense…
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
